Does “all disease begin in the gut”? The gut-organ cross talk in the microbiome
Applied Microbiology and Biotechnology · 2024-12 · 108 (1)
DOI: 10.1007/s00253-024-13180-9 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Applied Microbiology and Biotechnology, online erschienen am 21.05.2024. Verfasst von Prem Prashant Chaudhary und 2 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Clinical Immunology and Microbiology, Epithelial Therapeutics Unit, National Institute of Allergy and Infectious Disease, National Inst…. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 187 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
The human microbiome, a diverse ecosystem of microorganisms within the body, plays pivotal roles in health and disease. This review explores site-specific microbiomes, their role in maintaining health, and strategies for their upkeep, focusing on oral, lung, vaginal, skin, and gut microbiota, and their systemic connections. Understanding the intricate relationships between these microbial communities is crucial for unraveling mechanisms underlying human health. Recent research highlights bidirectional communication between the gut and distant microbiome sites, influencing immune function, metabolism, and disease susceptibility. Alterations in one microbiome can impact others, emphasizing their interconnectedness and collective influence on human physiology. The therapeutic potential of gut microbiota in modulating distant microbiomes offers promising avenues for interventions targeting various disorders. Through interdisciplinary collaboration and technological advancements, we can harness the power of the microbiome to revolutionize healthcare, emphasizing microbiome-centric approaches to promote holistic well-being while identifying areas for future research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratory of Clinical Immunology and Microbiology, Epithelial Therapeutics Unit, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, MD, 20892, USA. chaudharyp2@nih.gov.
- Laboratory of Clinical Immunology and Microbiology, Epithelial Therapeutics Unit, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, MD, 20892, USA.
Förderung
- Division of Intramural Research, National Institute of Allergy and Infectious Diseases
- National Institute of Allergy and Infectious Diseases
Zitieren
APA
Chaudhary, P. P., Kaur, M., & Myles, I. A. (2024). Does “all disease begin in the gut”? The gut-organ cross talk in the microbiome. Applied Microbiology and Biotechnology, 108(1). https://doi.org/10.1007/s00253-024-13180-9
Vancouver
Chaudhary PP, Kaur M, Myles IA. Does “all disease begin in the gut”? The gut-organ cross talk in the microbiome. Applied Microbiology and Biotechnology. 2024;108(1). doi:10.1007/s00253-024-13180-9
BibTeX
@article{Chaudhary2024,
author = {Chaudhary, Prem Prashant and Kaur, Mahaldeep and Myles, Ian A},
title = {Does “all disease begin in the gut”? The gut-organ cross talk in the microbiome},
journal = {Applied Microbiology and Biotechnology},
year = {2024},
volume = {108},
number = {1},
doi = {10.1007/s00253-024-13180-9}
}
EUVIMED